ATE387212T1 - Zusammensetzung aus hagebutte und fischöl zur linderung von gelenkschmerzen und steifheit - Google Patents

Zusammensetzung aus hagebutte und fischöl zur linderung von gelenkschmerzen und steifheit

Info

Publication number
ATE387212T1
ATE387212T1 AT01978231T AT01978231T ATE387212T1 AT E387212 T1 ATE387212 T1 AT E387212T1 AT 01978231 T AT01978231 T AT 01978231T AT 01978231 T AT01978231 T AT 01978231T AT E387212 T1 ATE387212 T1 AT E387212T1
Authority
AT
Austria
Prior art keywords
stiffness
fish oil
rosehip
composition
joint pain
Prior art date
Application number
AT01978231T
Other languages
English (en)
Inventor
Eydbjorg Rein
Original Assignee
Hansen Otto Torbjorn
Hansen Marianne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hansen Otto Torbjorn, Hansen Marianne filed Critical Hansen Otto Torbjorn
Application granted granted Critical
Publication of ATE387212T1 publication Critical patent/ATE387212T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
AT01978231T 2000-10-23 2001-10-22 Zusammensetzung aus hagebutte und fischöl zur linderung von gelenkschmerzen und steifheit ATE387212T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/694,764 US6485752B1 (en) 2000-10-23 2000-10-23 Composition and method for alleviating joint pain and stiffness

Publications (1)

Publication Number Publication Date
ATE387212T1 true ATE387212T1 (de) 2008-03-15

Family

ID=24790170

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01978231T ATE387212T1 (de) 2000-10-23 2001-10-22 Zusammensetzung aus hagebutte und fischöl zur linderung von gelenkschmerzen und steifheit

Country Status (11)

Country Link
US (1) US6485752B1 (de)
EP (1) EP1337263B1 (de)
AT (1) ATE387212T1 (de)
AU (1) AU2002210404A1 (de)
CY (1) CY1107930T1 (de)
DE (1) DE60133030T2 (de)
DK (1) DK1337263T3 (de)
ES (1) ES2301565T3 (de)
PT (1) PT1337263E (de)
SI (1) SI1337263T1 (de)
WO (1) WO2002034274A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8633247B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
US8633246B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
KR101245440B1 (ko) * 2003-09-12 2013-03-19 액세스 비지니스 그룹 인터내셔날 엘엘씨 사이토킨 조절물질 및 관련된 용도
US7758902B2 (en) * 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US7758903B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US8075910B2 (en) * 2004-05-20 2011-12-13 Pbm Pharmaceuticals, Inc. Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US9801913B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Barrier layer
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2006036982A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Drug delivery coating for use with a stent
US9592324B2 (en) 2006-11-06 2017-03-14 Atrium Medical Corporation Tissue separating device with reinforced support for anchoring mechanisms
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
WO2008006589A2 (en) * 2006-07-14 2008-01-17 Dsm Ip Assets B.V. Compositions comprising rosehip and other active agents for the treatment of inflammatory disorders
US20080031869A1 (en) * 2006-08-02 2008-02-07 Fontaine Juliette S Pain relief composition
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
US20080207756A1 (en) * 2007-02-27 2008-08-28 Atrium Medical Corporation Bio-absorbable oil suspension
HRP20150593T1 (hr) 2007-12-21 2015-07-31 Finzelberg Gmbh & Co. Kg Pripravci s ekstraktima šipka i postupak proizvodnje ekstrakta šipka
US9173912B2 (en) * 2008-05-06 2015-11-03 Finzelberg Gmbh & Co. Kg Cistus extract containing enriched secondary plant ingredients
EP2349281A1 (de) * 2008-10-30 2011-08-03 Hyben Vital Licens ApS Zusammensetzung mit einem glykosid einer mono- oder diacylglycerinverbindung und einem an mehrfach ungesättigten n-3-fettsäuren reichen öl sowie verfahren zur herstellung der zusammensetzung und verwendung der zusammensetzung
US20100215781A1 (en) * 2009-02-25 2010-08-26 Joar Opheim Therapeutic composition comprising omega-3 polyunsaturated fatty acid or derivative thereof, resveratrol and green tea
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
US20110045050A1 (en) * 2009-08-24 2011-02-24 Atrium Medical Corporation Nanoemulsion formulations for direct delivery
DK177605B1 (en) 2010-03-16 2013-11-18 Hyben Vital Licens Aps Compositions of rose hips enriched with seeds of rose hips and their use as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and joint diseases such as arthritis and/or osteo-arthritis
US10322213B2 (en) 2010-07-16 2019-06-18 Atrium Medical Corporation Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
WO2016173995A1 (en) 2015-04-28 2016-11-03 Hyben Vital Licens Aps Rose hip product comprising rose hip seeds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4774229A (en) 1982-04-05 1988-09-27 Chemex Pharmaceuticals, Inc. Modification of plant extracts from zygophyllaceae and pharmaceutical use therefor
JPH062677B2 (ja) * 1984-05-26 1994-01-12 日産化学工業株式会社 造血臓器回復促進剤
US4565690A (en) 1985-04-12 1986-01-21 Elena Avram Method for treating drug addiction
US5032400A (en) * 1989-11-02 1991-07-16 Erie Laboratories Shark liver oil and garlic oil topical analgesic
JP3172177B2 (ja) * 1990-11-14 2001-06-04 イミュー プロダクツ ウェスターン オーストレイリア ピーティーワイ． リミテッド エミュー油から誘導した抗炎性混合物
CN1102993A (zh) 1993-12-21 1995-05-31 吴文才 多酶体系加工中草药的制剂方法
US5397778A (en) * 1994-02-25 1995-03-14 New England Deaconess Hospital Corporation Enteral formulations for treatment of inflammation and infection
US5585118A (en) 1995-06-02 1996-12-17 Brigham And Women's Hospital Choline in the treatment of bipolar disorder
US5744187A (en) 1996-12-16 1998-04-28 Gaynor; Mitchel L. Nutritional powder composition
US5840278A (en) 1997-02-20 1998-11-24 Coleman; Thomas Nasal spray having a mineral vitamin component, a mineral component and aloe vera
US6024960A (en) 1998-04-17 2000-02-15 Otto Torbjorn Hansen And Marianne Hansen Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis
PT1156814E (pt) * 1999-03-03 2004-01-30 Eurovita A S Compostos farmaceuticos suplementos dieteticos e composicoes cosmeticas compreendendo um acido gordo e gengibre

Also Published As

Publication number Publication date
EP1337263A1 (de) 2003-08-27
ES2301565T3 (es) 2008-07-01
DE60133030D1 (de) 2008-04-10
CY1107930T1 (el) 2013-09-04
DE60133030T2 (de) 2009-03-19
AU2002210404A1 (en) 2002-05-06
WO2002034274A1 (en) 2002-05-02
DK1337263T3 (da) 2008-06-09
US6485752B1 (en) 2002-11-26
EP1337263B1 (de) 2008-02-27
SI1337263T1 (sl) 2008-08-31
PT1337263E (pt) 2008-05-09

Similar Documents

Publication Publication Date Title
DE60133030D1 (de) Erung von gelenkschmerzen und steifheit
BR0313492A (pt) Formulação de anticorpos humanos para tratar distúrbios associados ao tnf-alfa
EA200601776A1 (ru) Метадоновые композиции местного действия и способы их применения
ATE291433T1 (de) Extrakte von mutterkraut (tanacetum parthenium) gegen entzündliche erkrankungen
DE69400799D1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
BR0008926A (pt) Utilização de um extrato de uva, rico ouenriquecido em polifenóis e processo detratamento cosmético do corpo humano
MXPA04003666A (es) Uso de flibanserina para tratamiento de trastornos sexuales.
BRPI0509140A (pt) processos para o tratamento de infecção por hiv
EP1935418A4 (de) Zusammensetzung zur linderung von subjektiven müdigkeitssymptomen
DK1463735T3 (da) Imidazo-2,1-B -1,3,4-thiadiazol-sulfonamider
BR9913337A (pt) Derivados tan-1057
MA29625B1 (fr) Immunoglobulines
BRPI0415187A (pt) composição, método para matar bactérias, e, usos de composição e de bacteriófago
DE69927260D1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
AR046772A1 (es) Medicamento que comprende ptx3, solo o en combinacion con tsg-6, para tratar enfermedades degenerativas de cartilago y hueso y tratar la infertilidad femenina
DK1212072T3 (da) Farmaceutisk præparat omfattende eukalyptus- og orangeolie
BR0210910A (pt) Derivados de imidazotriazinonas e sua aplicação contra processos inflamatórios e/ou doenças imunes
MD1140C2 (ro) Remediu cu acţiune regenerativă şi citoprotectoare
DE60005548D1 (de) Zusammensetzung enthaltend einen extrakt aus perna canaliculus, methylsulfonylmethan und glucosamine und verwendung
ATE369143T1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
ATE239487T1 (de) Aphrodisiakum zur anwendung an den geschlechtsorganen
BRPI0412243A (pt) uso de cd164 solúvel em distúrbios inflamatórios e/ou autoimunes
KR920011502A (ko) 인체 신경계의 통증을 치료할 수 있는 부자이중탕(附子理中湯)의 개량된 한방치료제 물질
FR2846240B1 (fr) Onguent pour le corps, concu pour soulager et faire disparaitre progressivement les douleurs musculaires, foulures, entorses, deboitements, descongestionnants et pour apaiser les douleurs articulaires et rhumatismales.
HUP9701606A2 (hu) Szulbutiamin alkalmazása bizonyos pszichomotoros és pszichointellektuális rendellenességek kezelésére használható gyógyszerkészítmények előállítására

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1337263

Country of ref document: EP

REN Ceased due to non-payment of the annual fee